Search results
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Digital Journal· 2 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
WJET - WFXP Erie· 21 hours agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 2 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 2 days agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoPlanegg/Martinsried, May 21, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for solid tumors and
mRNA Vaccines vs. the Pandemic
The North Coast Journal· 2 days ago"I knew that [mRNA] can be used for everything and I had a kind of a Cassandra feeling, that I can see the future and nobody believes me." About 13...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 1 week agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
